Biotech Acquisition Co - Warrants (30/11/2027) Operating Income

As of the most recent data (September 2022), BIOTW shows a operating income of $-3.7M. That compares with $-1.1M in the prior-year period — down 243.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOTW's operating income is now $-3.7M (was $-1.1M) — a 243.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biotech Acquisition Co - Warrants (30/11/2027) is outperforming or lagging.

Tracking BIOTW's operating income over time shows whether Biotech Acquisition Co - Warrants (30/11/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $-3.7M That compares with $-1.1M in the prior-year period — down 243.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Biotech Acquisition Co - Warrants (30/11/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-3.7M) with ownership activity and broader fundamentals.